Pharmacological Modulation of Endogenous Opioid Activity to Attenuate Neuropathic Pain in Rats.

Abstract

We showed previously that spinal metabotropic glutamate receptor 1 (mGluR1) signaling suppresses or facilitates (depending on the stage of estrous cycle) analgesic responsiveness to intrathecal endomorphin 2, a highly mu-opioid receptor-selective endogenous opioid. Spinal endomorphin 2 antinociception is suppressed during diestrus by mGluR1 when it is activated by membrane estrogen receptor alpha (mERα) and is facilitated during proestrus when mGluR1 is activated by glutamate. In the current study, we tested the hypothesis that in female rats subjected to spinal nerve ligation (SNL), the inhibition of spinal estrogen synthesis or blockade of spinal mERα/mGluR1 would be antiallodynic during diestrus, whereas during proestrus, mGluR1 blockade would worsen the mechanical allodynia. As postulated, following SNL, aromatase inhibition or mERα/mGluR1 blockade during diestrus markedly lessened the mechanical allodynia. This was observed only on the paw ipsilateral to SNL and was eliminated by naloxone, implicating endogenous opioid mediation. In contrast, during proestrus, mGluR1 blockade worsened the SNL-induced mechanical allodynia of the ipsilateral paw. Findings suggest menstrual cycle stage-specific drug targets for and the putative clinical utility of harnessing endogenous opioids for chronic pain management in women, as well as the value of, if not the necessity for, considering menstrual cycle stage in clinical trials thereof. PERSPECTIVE: Intrathecal treatments that enhance spinal endomorphin 2 analgesic responsiveness under basal conditions lessen mechanical allodynia in a chronic pain model. Findings provide a foundation for developing drugs that harness endogenous opioid antinociception for chronic pain relief, lessening the need for exogenous opioids and thus prescription opioid abuse.

• Authors: Nai-Jiang Liu, Emiliya M Storman, Alan R Gintzler
• Journal: The journal of pain (J Pain) Vol. 20 Issue 2 Pg. 235-243 (02 2019) ISSN: 1528-8447 [Electronic] United States
• PMID: 30366152 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
• Copyright: Copyright © 2018 the American Pain Society. Published by Elsevier Inc. All rights reserved.

Chemical References

• Aromatase Inhibitors
• Estrogen Receptor alpha
• Oligopeptides
• Receptors, Metabotropic Glutamate
• metabotropic glutamate receptor type 1
• endomorphin 2

Topics

• Animals
• Aromatase Inhibitors (pharmacology)
• Chronic Pain (drug therapy, metabolism)
• Disease Models, Animal
• Estrogen Receptor alpha (drug effects, metabolism)
• Estrous Cycle (metabolism)
• Female
• Hyperalgesia (drug therapy, metabolism)
• Neuralgia (drug therapy, metabolism)
• Oligopeptides (drug effects, metabolism)
• Rats
• Rats, Sprague-Dawley
• Receptors, Metabotropic Glutamate (drug effects, metabolism)
• Spinal Cord (drug effects, metabolism)